Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Ribbon Cutting Ceremony Opens Doors to State-of-the Art Nanotechnology Facility in Pennsylvania’s New “Silicon Valley” Interviews Available with Founder

Abstract:
A Science Prodigy and Now CEO at Age 25

Debut of Technology Designed to Change the World One Atom at a Time

Ribbon Cutting Ceremony Opens Doors to State-of-the Art Nanotechnology Facility in Pennsylvania’s New “Silicon Valley” Interviews Available with Founder

Malvern, PA | Posted on June 18th, 2009

Who: Carbon Nanoprobes, Inc./CEO and Founder Brian Ruby

What: Five years in the making and with millions invested, Carbon Nanoprobes, Inc. is opening its doors for an inside view of how one firm has harnessed the intricate technology of the future.

· Twenty-five year old founder and CEO Brian Ruby will demonstrate what some call "mind-bending science," discuss his life story* and tell why he came from Seattle to PA.

· Today, Nanotechnology is playing a vital role in the region as well as the nation's economy. This cutting edge science is already having an impact in the way products and services are developed in terms of cost, precision and efficiency. Nanotechnology is also expected to have major implications for medical fields - like cancer research, and play a key role in robotics, solar energy, and the nation's quality of life.

· Just Imagine: Golf balls that fly straighter, wrinkle-free clothing, portable labs providing instant analysis of medical conditions, cosmetics with skin-healing properties, scratch resistant paints, and ultra precise drug agents - all part of the nano world of current and future possibilities.



Where: Carbon Nanoprobes, Inc., 363 Phoenixville Pike, Malvern, PA 19355; website: cnprobes.com

When: Thursday, June 25th, from 6:30 pm. to 9:00 p.m. Cocktails and food will be served.

*Bio of Founder: He imagined the future that is now. Twenty-five year old Brian Ruby achieved recognition for his insight into the complex field of applied science - beginning at age 15 when he interned at IBM's T.J. Watson Research Lab. There he learned how to make carbon nanotubes: he went on to win numerous awards at science fairs and a prestigious award from Intel. From there, Ruby worked at Progenics Pharmaceuticals on HIV vaccine research involving the study of microscopic proteins. Then - at age 22, as a sophomore engineering student at Columba University - this remarkable science prodigy came up with an innovative method of mass producing carbon nanoprobes, which led him to file for a patent and start his company.

More: Nanotechnology is an intriguing hybrid that draws on the most sophisticated quantum physics and molecular chemistry. "Nano" is Greek for "dwarf" and looks at matter between 1 and 100 nanometers in size. Considered the science of small things, a nanometer is a billionth of a meter - barely the size of 10 hydrogen atoms in a row. A human hair, for example, generally measures 80,000 nanometers across. Today, researchers are hard at work developing new nanotechnology applications across a wide range of industries, including biopharmaceuticals, advanced materials, agriculture, electronics, energy, defense, and transportation.

####

For more information, please click here

Contacts:
For press RSVPs
484.343.4826


For media inquiries and to arrange day of contact press coverage,
please contact
Tom Martin

203.297.2137

Copyright © Carbon Nanoprobes, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

Openings/New facilities/Groundbreaking/Expansion

NanoBio Announces Corporate Name Change to BlueWillow Biologics and Closes $10M Series A Financing: Move Reflects Focus on Advancing Several Intranasal Vaccines to Human Studies May 9th, 2018

Aculon Expands NanoProof® Product Line for Electronics Waterproofing Technology: With growing market opportunities Aculon Launches NanoProof® 8 with Push Through Connectivity™ and NanoProof® DAB a syringe application May 30th, 2017

GLOBALFOUNDRIES and Chengdu Partner to Expand FD-SOI Ecosystem in China: More than $100M investment to establish a center of excellence for FDXTM FD-SOI design May 23rd, 2017

GLOBALFOUNDRIES Expands to Meet Worldwide Customer Demand: Company invests for capacity growth in the United States, Germany, China and Singapore February 10th, 2017

Announcements

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

Tools

Carbon nanodots do an ultrafine job with in vitro lung tissue: New experiments highlight the role of charge and size when it comes to carbon nanodots that mimic the effect of nanoscale pollution particles on the human lung. September 12th, 2018

Terahertz spectroscopy enters the single-molecule regime September 7th, 2018

Mirrorcle Demonstrates MEMS-based Programmable Light Source at CES and PW18 August 30th, 2018

Stress-free ALD from Picosun August 28th, 2018

Events/Classes

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018 September 20th, 2018

Arrowhead Pharmaceuticals to Present at Upcoming September 2018 Conferences August 31st, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project